Voriconazole and Caspofungin Acetate in Treating Invasive Fungal Infections in Patients With Weakened Immune Systems
Status:
Terminated
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Voriconazole and caspofungin acetate may control invasive fungal infections in
patients who have weakened immune systems.
PURPOSE: This phase II trial is studying how well giving voriconazole together with
caspofungin acetate works in treating invasive fungal infections in patients with weakened
immune systems.